文献速递糖尿病肥胖与代谢综合征

维生素D补充对糖尿病前期患者预防2型糖尿病的影响:系统综述与Meta分析

Effects of Vitamin D Supplementation on Prevention of Type 2 Diabetes in Patients With Prediabetes: A Systematic Review and Meta-analysis.
PubMed 文献 · Diabetes Care · 2020-01-01

该系统综述与Meta分析纳入8项随机对照试验共4896例糖尿病前期患者,评估维生素D补充对比安慰剂对新发2型糖尿病的影响。结果显示维生素D补充显著降低2型糖尿病风险(RR 0.89,95%CI 0.80-0.99),并提高糖尿病前期逆转为正常血糖率(RR 1.48,95%CI 1.14-1.92),获益主要见于非肥胖者。

要点

  • 维生素D补充降低糖尿病前期患者2型糖尿病风险(RR 0.89)。
  • 维生素D补充提高糖尿病前期逆转为正常血糖率(RR 1.48)。
  • 预防2型糖尿病的获益可能仅限于非肥胖者。

核心结论

  • 在糖尿病前期人群中,维生素D补充可降低2型糖尿病风险并提高逆转为正常血糖率。
  • 预防2型糖尿病的获益可能仅限于非肥胖者。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE、Embase和Cochrane CENTRAL自建库至2019年7月5日。
  • 纳入8项随机对照试验,共4896例糖尿病前期受试者,比较维生素D补充与安慰剂。

主要发现

  • 维生素D补充显著降低2型糖尿病风险(RR 0.89 [95% CI 0.80-0.99];I²=0%)。
  • 非肥胖者中获益显著(RR 0.73 [95% CI 0.57-0.92]),肥胖者中不显著(RR 0.95 [95% CI 0.84-1.08])(P interaction=0.048)。
  • 糖尿病前期逆转为正常血糖:维生素D组548例中116例(21.2%),对照组532例中75例(14.1%)。
  • 维生素D补充提高糖尿病前期逆转为正常血糖率(RR 1.48 [95% CI 1.14-1.92];I²=0%)。

临床怎么用

  • 对糖尿病前期患者,可考虑补充维生素D以降低2型糖尿病风险并促进血糖正常化。
  • 非肥胖的糖尿病前期患者可能从维生素D补充中获益更明显。

局限性

  • 纳入研究中糖尿病前期和新发糖尿病的定义不一致。
  • 缺乏2型糖尿病预防结局的长期数据。
  • 需个体参与者数据Meta分析确认上述发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While observational studies have shown an association between vitamin D insufficiency and diabetes, it is unclear whether intervention with vitamin D supplements can lower the risk of type 2 diabetes mellitus (T2DM). PURPOSE: To assess whether vitamin D supplementation reduces the risk of T2DM in people with prediabetes. DATA SOURCES: We searched MEDLINE, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) from inception to 5 July 2019. STUDY SELECTION: We included randomized controlled trials assessing vitamin D supplementation versus placebo in relation to new-onset T2DM in people with prediabetes. DATA EXTRACTION: We screened studies and extracted data from published trials independently. DATA SYNTHESIS: We identified eight eligible trials with a total of 4,896 subjects. Vitamin D supplementation significantly reduced the risk of T2DM (risk ratio [RR] 0.89 [95% CI 0.80-0.99]; I 2 = 0%). Benefit was found in nonobese subjects (RR 0.73 [95% CI 0.57-0.92]) but not in obese subjects (RR 0.95 [95% CI 0.84-1.08]) (P interaction = 0.048). The reversion of prediabetes to normoglycemia occurred in 116 of 548 (21.2%) participants in the vitamin D group and 75 of 532 (14.1%) in the control group. Vitamin D supplementation increased reversion rate of prediabetes to normoglycemia (RR 1.48 [95% CI 1.14-1.92]; I 2 = 0%.) LIMITATIONS: Definitions of prediabetes and new-onset diabetes in eligible studies were different, and long-term data on outcomes of T2DM prevention were lacking. CONCLUSIONS: In persons with prediabetes, vitamin D supplementation reduces the risk of T2DM and increases the reversion rate of prediabetes to normoglycemia. The benefit of the prevention of T2DM could be limited to nonobese subjects. Individual participant data meta-analyses are needed to confirm these findings.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Tan H, Tang J, et al. Effects of Vitamin D Supplementation on Prevention of Type 2 Diabetes in Patients With Prediabetes: A Systematic Review and Meta-analysis. Diabetes Care. 2020. PMID: 33534730. doi:10.2337/dc19-1708

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。